Brief: Harvard Bioscience Says Qtrly EPS $0.06

Harvard Bioscience

04/08/2022 03:52

Aug 3 (Reuters) - Harvard Bioscience Inc  HBIO.O :
    * HARVARD BIOSCIENCE ANNOUNCES SECOND QUARTER 2022 FINANCIAL
RESULTS
    * QTRLY EPS $0.06
    * QTRLY DILUTED ADJUSTED EARNINGS PER SHARE $0.05
    * QTRLY REVENUE $29.2 MILLION VERSUS $29.2 MILLION A YEAR
AGO
    * SEES FY 2022 REVENUE GROWTH 1-TO-5%  AND ADJUSTED
OPERATING
MARGIN OF 13-TO-14%

Source text for Eikon:  ID:nGNX3CrqLS 
Further company coverage:  HBIO.O 

 ((Reuters.briefs@thomsonreuters.com;))